Clopidogrel: all 338 studies that test it

Page 3 of 4. Open to participants first (32), then studies with results posted, then the rest; newest registration first within each.

• Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI PatientsCompletedNCT01779401Not applicable
• Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary SyndromeStatus unknownNCT01778842Phase 3
• Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of DigoxinCompletedNCT01775839Phase 4
• Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic NephropathyStatus unknownNCT01743014Phase 4
• Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary InterventionStatus unknownNCT01738100Phase 2
• Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian PatientsCompletedNCT01706510Phase 4
• Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor StudyCompletedNCT01700322Phase 4
• Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVICompletedNCT01642134Phase 4
• Effect of the Repeated Loading Dose of Clopidogrel and High Dose of Clopidogrel Continuous Therapy on the Platelet Aggregation Inhibition in Patients With Myocardial Infarction Undergoing Interventional Treatment.WithdrawnNCT01636180Phase 4
• Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent MiscarriagesStatus unknownNCT01635426Phase 2/3
• Residual Platelet Activity In Advanced Peripheral Artery DiseaseStatus unknownNCT01627431Phase 4
• Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed ConditionsCompletedNCT01621763Phase 1
• Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting ConditionsCompletedNCT01621750Phase 1
• A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy VolunteersCompletedNCT01603342Phase 1
• Clopidogrel and Atorvastatin Treatment During Carotid Artery StentingStatus unknownNCT01572623Phase 4
• Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel TherapyStatus unknownNCT01572129Phase 4
• Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE TrialCompletedNCT01559298Phase 4
• High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable PatientsCompletedNCT01543932Phase 3
• Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed ConditionsCompletedNCT01512485Phase 1
• Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27CompletedNCT01509365Phase 4
• Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01506713Phase 1
• Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary InterventionCompletedNCT01505790Phase 3
• Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of ClopidogrelCompletedNCT01503658Phase 4
• The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy VolunteersCompletedNCT01482117Not applicable
• Drug Interaction Study of Clopidogrel and RosuvastatinCompletedNCT01469416Phase 1
• Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE TrialCompletedNCT01465828Phase 3
• Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and ClopidogrelCompletedNCT01456546Phase 1
• Comparative Bioavailability Study of Two Oral Formulations of ClopidogrelTerminatedNCT01447563Phase 1
• Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)CompletedNCT01431495Phase 4
• To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their EffectsCompletedNCT01409616Phase 1
• Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary InterventionTerminatedNCT01339026Phase 4
• Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet ActivityCompletedNCT01335048Phase 4
• Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney DiseaseCompletedNCT01328470Phase 4
• Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese PatientsCompletedNCT01325935Phase 4
• Anti-Platelet Drugs and Brain-derived Neurotrophic Factor (BDNF) in Human Serum and PlasmaStatus unknownNCT01264640Not applicable
• Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent ImplantationStatus unknownNCT01233167Not applicable
• An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of ClopidogrelCompletedNCT01210339Phase 1
• Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)CompletedNCT01186146Phase 4
• Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.CompletedNCT01175200Not applicable
• Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass GraftingCompletedNCT01159639Phase 4
• Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMIStatus unknownNCT01158846Phase 4
• Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of ClopidogrelCompletedNCT01147588Phase 1
• Comparison of Generic and Original Formulation of ClopidogrelCompletedNCT01147133Phase 4
• Platelet Inhibition and Transcranial Doppler (TCD)-Detected Microemboli During and After Carotid Artery Stenting (CAS) in Asymptomatic Patients Prior to Cardiac SurgeryCompletedNCT01146301Phase 4
• Anticoagulation in Stent InterventionStatus unknownNCT01141153Phase 4
• Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCICompletedNCT01135667Phase 4
• Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy SubjectsCompletedNCT01129427Phase 1
• Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy SubjectsCompletedNCT01129414Phase 1
• Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy SubjectsCompletedNCT01129388Phase 1
• Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy SubjectsCompletedNCT01129375Phase 1
• Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy SubjectsCompletedNCT01129271Phase 1
• Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy SubjectsCompletedNCT01129063Phase 1
• Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy SubjectsCompletedNCT01123824Phase 1
• Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor - Optimize TrialCompletedNCT01113372Phase 4
• Effects of Clopidogrel on Blood PressureCompletedNCT01112137Phase 4
• Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167)CompletedNCT01108588Phase 1
• Plavix, Prasugrel and Drug Eluting Stents Pilot TrialStatus unknownNCT01103843Not applicable
• Clopidogrel/Aspirin Interaction StudyCompletedNCT01102439Phase 4
• Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent ImplantationCompletedNCT01094457Phase 4
• Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in JapanCompletedNCT01069302Phase 4
• ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft SurgeryStatus unknownNCT01046942Phase 3
• The EFFect of hIgh Dose ClopIdogrel treatmENT in Patients With Clopidogrel ResistanceCompletedNCT01032668Phase 3
• Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ AssayStatus unknownNCT01023360Phase 4
• Platelet Reactivity in Stent Thrombosis PatientsCompletedNCT01012544Phase 4
• Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.WithdrawnNCT01011257Phase 4
• Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular EventsCompletedNCT00979589Phase 3
• Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD EquivalentsCompletedNCT00947843Phase 4
• Second Generation" Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet TherapyTerminatedNCT00944333Phase 3
• Clopidogrel and Aspirin for the Treatment of Polycythemia VeraWithdrawnNCT00940784Phase 2
• Ex Vivo Human Thrombosis Chamber StudyCompletedNCT00935506Phase 1
• Tailoring Of Platelet Inhibition to Avoid Stent ThrombosisCompletedNCT00914368Phase 2
• Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) PolymorphismStatus unknownNCT00891670Phase 3
• Safety and Efficacy of Three Different Loading Doses of Clopidogrel, in Patients With Acute Myocardial InfarctionCompletedNCT00882739Phase 4
• The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal VolunteersCompletedNCT00882388Phase 4
• Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial DiseaseCompletedNCT00862420Phase 3
• Resistance to Antithrombotic TherapyCompletedNCT00858715Not applicable
• Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet TherapyCompletedNCT00827411Phase 4
• Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary AngioplastyCompletedNCT00827346Phase 2/3
• Clopidogrel and Response Variability Investigation Study 2CompletedNCT00822666Phase 3
• Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent ImplantationCompletedNCT00822536Phase 4
• Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being PlannedCompletedNCT00821834Phase 3
• COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic StrokeCompletedNCT00814268Phase 4
• Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal DefectsCompletedNCT00799045Phase 4
• Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)CompletedNCT00781573Not applicable
• Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal UlcersCompletedNCT00778193Phase 4
• Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent ImplantationStatus unknownNCT00776633Phase 4
• The Clopidogrel and Aspirin After Surgery for Coronary Artery DiseaseStatus unknownNCT00776477Phase 3
• Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular EventsStatus unknownNCT00775762Phase 3
• Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI)Status unknownNCT00751491Phase 3
• Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)CompletedNCT00728156Phase 4
• Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery.CompletedNCT00724880Phase 4
• CASTLE (Clopidogrel And Serum Troponin Level Elevation)CompletedNCT00716924Phase 3
• Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial InfarctionCompletedNCT00714961Phase 3
• Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTingCompletedNCT00698607Phase 4
• Healthy Volunteer Study of Clopidogrel and RifampicinCompletedNCT00696566Phase 1
• Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet FunctionCompletedNCT00693069Phase 3
• Anticoagulant Treatments and Percutaneous Coronary AngioplastyTerminatedNCT00669149Phase 4
• Standard Medical Management in Secondary Prevention of Ischemic Stroke in ChinaCompletedNCT00664846Not applicable
• Warfarin After Anterior ST-Elevation Myocardial InfarctionCompletedNCT00662467Not applicable
• Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting StentingStatus unknownNCT00661206Phase 4

← Clopidogrel overview